Dorlo TPC - Search Results

1

Skin tissue sample collection, sample homogenization, and analyte extraction strategies for liquid chromatographic mass spectrometry quantification of pharmaceutical compounds.

Roseboom IC, Rosing H, Beijnen JH, Dorlo TPC. Roseboom IC, et al. Among authors: dorlo tpc. J Pharm Biomed Anal. 2020 Nov 30;191:113590. doi: 10.1016/j.jpba.2020.113590. Epub 2020 Aug 28. J Pharm Biomed Anal. 2020. PMID: 33010602 Free article. Review.

2

Power to identify exposure-response relationships in phase IIa pulmonary tuberculosis trials with multi-dimensional bacterial load modeling.

Koele SE, Dorlo TPC, Upton CM, Aarnoutse RE, Svensson EM. Koele SE, et al. Among authors: dorlo tpc. CPT Pharmacometrics Syst Pharmacol. 2024 Mar;13(3):374-385. doi: 10.1002/psp4.13089. Epub 2023 Dec 15. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 38102814 Free PMC article.

3

[Miltefosine: a new remedy for leishmaniasis].

Dorlo TP, Eggelte TA, Beijnen JH, de Vries PJ. Dorlo TP, et al. Ned Tijdschr Geneeskd. 2006 Dec 9;150(49):2697-701. Ned Tijdschr Geneeskd. 2006. PMID: 17194005 Review. Dutch.

4

Development and validation of a quantitative assay for the measurement of miltefosine in human plasma by liquid chromatography-tandem mass spectrometry.

Dorlo TP, Hillebrand MJ, Rosing H, Eggelte TA, de Vries PJ, Beijnen JH. Dorlo TP, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Apr 1;865(1-2):55-62. doi: 10.1016/j.jchromb.2008.02.005. Epub 2008 Feb 20. J Chromatogr B Analyt Technol Biomed Life Sci. 2008. PMID: 18325856

5

Pharmacokinetics of miltefosine in Old World cutaneous leishmaniasis patients.

Dorlo TP, van Thiel PP, Huitema AD, Keizer RJ, de Vries HJ, Beijnen JH, de Vries PJ. Dorlo TP, et al. Antimicrob Agents Chemother. 2008 Aug;52(8):2855-60. doi: 10.1128/AAC.00014-08. Epub 2008 Jun 2. Antimicrob Agents Chemother. 2008. PMID: 18519729 Free PMC article. Clinical Trial.

6

Severe encephalopathy and polyneuropathy induced by dichloroacetate.

Brandsma D, Dorlo TP, Haanen JH, Beijnen JH, Boogerd W. Brandsma D, et al. J Neurol. 2010 Dec;257(12):2099-100. doi: 10.1007/s00415-010-5654-9. Epub 2010 Jul 15. J Neurol. 2010. PMID: 20632025 No abstract available.

7

Dynamics of parasite clearance in cutaneous leishmaniasis patients treated with miltefosine.

Dorlo TP, van Thiel PP, Schoone GJ, Stienstra Y, van Vugt M, Beijnen JH, de Vries PJ. Dorlo TP, et al. PLoS Negl Trop Dis. 2011 Dec;5(12):e1436. doi: 10.1371/journal.pntd.0001436. Epub 2011 Dec 13. PLoS Negl Trop Dis. 2011. PMID: 22180803 Free PMC article.

8

Characterization and identification of suspected counterfeit miltefosine capsules.

Dorlo TP, Eggelte TA, de Vries PJ, Beijnen JH. Dorlo TP, et al. Analyst. 2012 Mar 7;137(5):1265-74. doi: 10.1039/c2an15641e. Epub 2012 Jan 18. Analyst. 2012. PMID: 22251969

9

Translational pharmacokinetic modelling and simulation for the assessment of duration of contraceptive use after treatment with miltefosine.

Dorlo TP, Balasegaram M, Lima MA, de Vries PJ, Beijnen JH, Huitema AD. Dorlo TP, et al. J Antimicrob Chemother. 2012 Aug;67(8):1996-2004. doi: 10.1093/jac/dks164. Epub 2012 May 10. J Antimicrob Chemother. 2012. PMID: 22577099

10

Optimal dosing of miltefosine in children and adults with visceral leishmaniasis.

Dorlo TP, Huitema AD, Beijnen JH, de Vries PJ. Dorlo TP, et al. Antimicrob Agents Chemother. 2012 Jul;56(7):3864-72. doi: 10.1128/AAC.00292-12. Epub 2012 May 14. Antimicrob Agents Chemother. 2012. PMID: 22585212 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

118 results

Search Page